144 related articles for article (PubMed ID: 2572322)
1. Rapid tranquilization with neuroleptic drugs. Neurologic concerns.
Lazarus A; Dubin WR; Jaffe RL
Clin Neuropharmacol; 1989 Aug; 12(4):303-11. PubMed ID: 2572322
[No Abstract] [Full Text] [Related]
2. Neuroleptic malignant syndrome after neuroleptic discontinuation.
Amore M; Zazzeri N
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212
[TBL] [Abstract][Full Text] [Related]
3. Case report of neuroleptic malignant syndrome with prolonged mental changes and severe dyskinesia.
Chung YJ; Lee SJ
Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 29464897
[No Abstract] [Full Text] [Related]
4. Neurologic complications of drugs. Tardive dyskinesias, neuroleptic malignant syndrome, and cocaine-related syndromes.
Rodnitzky RL; Keyser DL
Psychiatr Clin North Am; 1992 Jun; 15(2):491-510. PubMed ID: 1351285
[TBL] [Abstract][Full Text] [Related]
5. Rigidity and fever in two psychotic patients.
Greenberg MS; Gorelick PB
Hosp Pract (Off Ed); 1986 Jul; 21(7):171, 174. PubMed ID: 2873146
[No Abstract] [Full Text] [Related]
6. Neuroleptic rechallenge after neuroleptic malignant syndrome.
Giacardi-Paty M; Bottai T; Pujalte D; Lainey E; Petit P
Br J Psychiatry; 1993 Jul; 163():121-2. PubMed ID: 8102585
[No Abstract] [Full Text] [Related]
7. Dysphagia in a Case of Atypical Neuroleptic Malignant Syndrome.
Truong TD; Mason DP
J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):349-351. PubMed ID: 33734166
[No Abstract] [Full Text] [Related]
8. Neuroleptic-induced respiratory dyskinesia.
Kruk J; Sachdev P; Singh S
J Neuropsychiatry Clin Neurosci; 1995; 7(2):223-9. PubMed ID: 7626967
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced movement disorders.
Gershanik OS
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
[TBL] [Abstract][Full Text] [Related]
10. Dysphagia in the neuroleptic malignant syndrome.
Shamash J; Miall L; Williams F; Creamer D; Robinson S; Johnston DG
Br J Psychiatry; 1994 Jun; 164(6):849-50. PubMed ID: 7953002
[No Abstract] [Full Text] [Related]
11. Neuroleptic malignant syndrome with risperidone.
Levin GM; Lazowick AL; Powell HS
J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
[No Abstract] [Full Text] [Related]
12. Neuroleptic malignant syndrome: a preventive program.
Fernando ML; Manchanda R; Kirk C
J Psychiatry Neurosci; 1992 Mar; 17(1):31-3. PubMed ID: 1349827
[TBL] [Abstract][Full Text] [Related]
13. [Drug side effects on the nervous system].
Ludin HP
Ther Umsch; 1993 Jan; 50(1):23-7. PubMed ID: 8104359
[TBL] [Abstract][Full Text] [Related]
14. Rapid improvement of neuroleptic-induced tardive dyskinesia with levetiracetam in an interictal psychotic patient.
Chen PH; Liu HC
J Clin Psychopharmacol; 2010 Apr; 30(2):205-7. PubMed ID: 20520300
[No Abstract] [Full Text] [Related]
15. [The malignant neuroleptic syndrome].
Pietzcker A
Nervenarzt; 1988 Dec; 59(12):691-700. PubMed ID: 2905769
[No Abstract] [Full Text] [Related]
16. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
Heils A; Lesch KP
Fortschr Neurol Psychiatr; 1997 Jan; 65(1):8-15. PubMed ID: 9132369
[TBL] [Abstract][Full Text] [Related]
17. [Neuroleptic malignant syndrome].
Dahm JB; Trenckmann U
Med Klin (Munich); 1991 Nov; 86(11):601-4. PubMed ID: 1685215
[No Abstract] [Full Text] [Related]
18. Sudden death and neuroleptic medication in subhuman primates.
Domino EF
Am J Psychiatry; 1985 Jan; 142(1):145. PubMed ID: 2857069
[No Abstract] [Full Text] [Related]
19. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
Peschel O; Kurtz G; Müller-Felber W; Modell S
Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
[TBL] [Abstract][Full Text] [Related]
20. Clozapine treatment and neuroleptic malignant syndrome.
Doan RJ; Callaghan WD
Can J Psychiatry; 2000 May; 45(4):394-5. PubMed ID: 10813077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
